Check Out What Whales Are Doing With BMY
Portfolio Pulse from Benzinga Insights
Deep-pocketed investors have shown a bearish sentiment towards Bristol-Myers Squibb (BMY), with a notable shift in options activity. Benzinga's tracking revealed 13 extraordinary options activities, with a bearish majority of 69% among investors. The options target a price range of $43.0 to $57.5 for BMY over the last 3 months. The company, a leader in immuno-oncology, shows a significant U.S. market dependence, with its stock price slightly up by 0.34% at $51.77.
March 19, 2024 | 5:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bristol-Myers Squibb has seen a bearish sentiment from large investors, with options activity suggesting a target price range of $43.0 to $57.5. The stock is currently up 0.34% at $51.77.
The bearish sentiment among deep-pocketed investors, indicated by the options activity, suggests a potential downside risk for BMY's stock price in the short term. The specific targeting of a price range between $43.0 and $57.5, combined with the current slight uptick in stock price, underscores the relevance of this sentiment. The high relevance and importance are due to the direct impact of investor sentiment and options activity on stock price movements. The confidence level reflects the clear bearish majority among investors and the detailed tracking of options activities.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100